For example, a study using trastuzumab-loaded liposomes (TRA-LPs) in HER2+ BC cells (SKBR3), in conjunction with mechanical FUS, demonstrated significant improvement in intratumoral drug accumulation post-FUS and resultant reduction in cell viability relative to controls (110). This evidence concerns the gene ERBB2 and breast cancer.